Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant human gelsolin |
---|---|
Date Designated: | 01/12/1994 |
Orphan Designation: | Treatment of the respiratory symptoms of cystic fibrosis. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BioAegis Therapeutics, Inc. 6 East Cove Lane Morristown, New Jersey 07960 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-